A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J
Anesth Analg 2004;99:262-271.
Review by
Menu